Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Interest Expenses (2020 - 2025)

Historic Interest Expenses for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $1.3 million.

  • Treace Medical Concepts' Interest Expenses rose 190.4% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 72.44%. This contributed to the annual value of $5.3 million for FY2024, which is 172.25% up from last year.
  • According to the latest figures from Q3 2025, Treace Medical Concepts' Interest Expenses is $1.3 million, which was up 190.4% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Treace Medical Concepts' Interest Expenses registered a high of $1.3 million during Q3 2025, and its lowest value of $946000.0 during Q2 2022.
  • Over the past 5 years, Treace Medical Concepts' median Interest Expenses value was $1.3 million (recorded in 2023), while the average stood at $1.2 million.
  • Its Interest Expenses has fluctuated over the past 5 years, first skyrocketed by 13378.68% in 2021, then plummeted by 886.32% in 2022.
  • Treace Medical Concepts' Interest Expenses (Quarter) stood at $1.0 million in 2021, then increased by 27.53% to $1.3 million in 2022, then fell by 0.53% to $1.3 million in 2023, then increased by 0.77% to $1.3 million in 2024, then grew by 1.83% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $1.3 million for Q2 2025, and $1.3 million during Q1 2025.